The Quintessential Ventricular Cannula

Information

  • Research Project
  • 6999160
  • ApplicationId
    6999160
  • Core Project Number
    R41HL082251
  • Full Project Number
    1R41HL082251-01
  • Serial Number
    82251
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2005 - 18 years ago
  • Project End Date
    7/31/2007 - 16 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    8/1/2005 - 18 years ago
  • Budget End Date
    7/31/2007 - 16 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/21/2005 - 18 years ago

The Quintessential Ventricular Cannula

DESCRIPTION (provided by applicant): Chronic mechanical circulatory support has been progressively migrating towards the use of turbo-dynamic blood pumps. For many reasons, these "second-" and "third-generation" devices offer advantages over the current pulsatile generation of ventricular assist devices. However, ventricular unloading with dynamic blood pumps can be markedly affected by the geometry of the cannula within the ventricular chamber. Due to the ability of these pumps to develop negative inflow pressure, existing cannula designed for passively-filling blood pumps can be predisposed to inflow occlusion by intraventricular anatomic structures, and deleterious hemodynamic flow patterns. The consequences may be catastrophic: causing thrombosis, and attendant morbidity and mortality. This project aims to develop a novel "trumpet" mouth cannula to overcome several of the limitations of existing cannula. Previous research by the P.I. has demonstrated the effectiveness of a trumpet shape to stent the ventricular apex, assure placement of the tip opening relative to the endocardial surface, and streamline the blood drainage through the inflow tract. The practical, clinical implementation of this cannula requires additional development, specifically concentrating on the means of deployment. This Phase-l effort will therefore seek to develop an efficient, practical, reliable cannulation method by systematic evaluation of two alternative deployment strategies. The design will be performed with the assistance of computer-aided engineering tools, and will be evaluated in vitro using flexible casts of both human and bovine ventricles. Final evaluation will be performed within transparent casts by flow visualization to select a cannula that accommodates a wide range of ventricular anatomies, avoids blood stagnation at the apex, and minimally interferes with the papillary structures. The final deliverable will be an optimized design suitable for in-vivo testing and preparation for mass production in a subsequent Phase-ll effort.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R41
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    237161
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:237161\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LAUNCHPOINT TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
    826728685
  • Organization City
    GOLETA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    93117
  • Organization District
    UNITED STATES